Insmed Inc (INSM) Company Report Oct. 27, 2022, 07:05 UTC 30 New SEC Filing for Insmed Inc. (NASDAQ:INSM) Comment Full text
Neurocrine Biosciences Inc (NBIX) Company Report Oct. 27, 2022, 06:44 UTC 37 Neurocrine Biosciences Initiates Phase 2 Clinical Study Evaluating NBI-1117568 in Adults with Schizophrenia Comment Full text
Rigel Pharmaceuticals Inc (RIGL) Company Report Oct. 27, 2022, 06:44 UTC 36 Rigel Announces Conference Call and Webcast to Report Third Quarter 2022 Financial Results and Business Update Comment Full text
Alnylam Pharmaceuticals Inc (ALNY) Company Report Oct. 27, 2022, 06:43 UTC 35 New Form 10-Q for Alnylam Pharmaceuticals, Inc. Comment Full text
Mustang Bio Inc (MBIO) Company Report Oct. 27, 2022, 06:21 UTC 37 Mustang Bio Announces Phase 1/2 Clinical Trial Data of MB-106, a First-in-Class CD20-targeted, Autologous CAR T Cell Therapy, to be Presented at 11th International Workshop for Waldenstroms Macroglobulinemia Comment Full text
Humanigen Inc. (HGEN) Company Report Oct. 26, 2022, 13:59 UTC 37 Humanigen Inc. Website - Validate Account Comment Full text
Supernus Pharmaceuticals Inc (SUPN) Company Report Oct. 25, 2022, 14:40 UTC 34 New Form 8-K for Supernus Pharmaceuticals Comment Full text
Enochian Biosciences Inc. (ENOB) Company Report Oct. 25, 2022, 11:36 UTC 36 Enochian Biosciences Inc. Website - Validate Account Comment Full text
Diffusion Pharmaceuticals Inc. (DFFN) Company Report Oct. 25, 2022, 06:58 UTC 34 Diffusion Pharmaceuticals Inc. - Validate Account Comment Full text
Applied Genetic Technologies Corporation (AGTC) Company Report Oct. 24, 2022, 14:32 UTC 35 New Form 10-K/A for Applied Genetic Technologies Corporation Comment Full text